Looking for the latest evidence from care guidelines and clinical trials in the management of immunoglobulin A nephropathy (IgAN)? Unsure which of the new and merging therapies may be best to consider for your patient with IgAN? In this E-monograph activity, Dr Mohamed Atta will review the important role of proteinuria in IgAN, and the impact of new and emerging therapies for IgAN to optimize proteinuria lowering in clinical practice and improve patient outcomes.